New enzyme drug tested in healthy volunteers

NCT ID NCT07484893

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-stage trial will test a new drug called recombinant human hyaluronidase in 24 healthy Chinese men. The drug is an enzyme that may help other medications spread more easily under the skin. The main goal is to check safety, how the body processes the drug, and whether it causes an immune response.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

recombinant human hyaluronidase

What this could lead to

If successful, this could help develop a drug that helps other medications spread more easily under the skin.

What could go wrong

This is a very early, small trial in healthy volunteers, so it won't test any disease treatment. The drug may cause allergic reactions or injection site issues.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY ADULT MALE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The Second Affiliated Hospital of Anhui Medical University

    Hefei, Anhui, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••